NMR interaction studies of Neu5Ac-&agr;-(2,6)-Gal-&bgr;-(1-4)-GlcNAc with influenza-virus hemagglutinin expressed in transfected human cells

The emergence of escape-mutants of influenza hemagglutinin (HA) following vaccination compels the yearly re-formulation of flu vaccines. Since binding the sialic acid receptor remains in all cases essential for infection, small-molecule inhibitors of HA binding to sialic acid could be interesting therapeutic complements or alternatives to immuno-prophylaxis in the control of flu epidemics. In this work, we made use of NMR spectroscopy to study the interaction between a derivative of sialic acid (the Neu5Ac-α-(2,6)-Gal-β-(1-4)-GlcNAc trisaccharide) and HAs (H1 and H5) from human and avian strains of influenza virus, directly expressed on the surface of stable transfected 293 T human cells. The HAs were shown to retain their native trimeric conformation and binding properties. Exploiting the magnetization transfer between the proteins and the ligand, we obtained evidence of the binding event and mapped the (non-identical) sugar epitopes recognized by the two HA species. The rapid and reliable method for screening sialic acid-related HA ligands we have developed could yield useful information for an efficient drug design.

[1]  D. Potenza,et al.  Transferred-NOE NMR experiments on intact human platelets: receptor-bound conformation of RGD-peptide mimics. , 2008, Organic & biomolecular chemistry.

[2]  David J. Stevens,et al.  Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptors , 2006, Nature.

[3]  U. Krengel,et al.  Both El Tor and classical cholera toxin bind blood group determinants. , 2012, Biochemical and biophysical research communications.

[4]  E. Yates,et al.  Human (α2→6) and avian (α2→3) sialylated receptors of influenza A virus show distinct conformations and dynamics in solution. , 2013, Biochemistry.

[5]  James C Paulson,et al.  Sweet spots in functional glycomics , 2006, Nature chemical biology.

[6]  G. Tiana,et al.  Thermodynamically-Weighted Conformational Ensemble of Cyclic RGD Peptidomimetics from NOE Data. , 2016, The journal of physical chemistry. B.

[7]  A. Monto,et al.  Pandemic Influenza: An Inconvenient Mutation , 2009, Science.

[8]  Carolyn N. Kingsley,et al.  Application of virus-like particles (VLP) to NMR characterization of viral membrane protein interactions , 2016, Journal of Biomolecular NMR.

[9]  Eugenia Pechkova,et al.  Solution structure of the β‐subunit of the translation initiation factor aIF2 from archaebacteria Sulfolobus solfataricus , 2008, Proteins.

[10]  U. Krengel,et al.  Comprehensive analysis of blood group antigen binding to classical and El Tor cholera toxin B-pentamers by NMR. , 2014, Glycobiology.

[11]  J. Nicholls,et al.  Avian influenza H5-containing virus-like particles (VLPs): host-cell receptor specificity by STD NMR spectroscopy. , 2008, Angewandte Chemie.

[12]  Ian A. Wilson,et al.  Glycan microarray technologies: tools to survey host specificity of influenza viruses , 2006, Nature Reviews Microbiology.

[13]  Ian A. Wilson,et al.  Structure and Receptor Specificity of the Hemagglutinin from an H5N1 Influenza Virus , 2006, Science.

[14]  C. Bewley.  Illuminating the switch in influenza viruses , 2008, Nature Biotechnology.

[15]  M. Civera,et al.  Insights into the Binding of Cyclic RGD Peptidomimetics to α5β1 Integrin by using Live‐Cell NMR And Computational Studies , 2016, ChemistryOpen.

[16]  H. Klenk,et al.  Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus. , 2005, Antiviral research.

[17]  E. Yates,et al.  Insights into the Human Glycan Receptor Conformation of 1918 Pandemic Hemagglutinin–Glycan Complexes Derived from Nuclear Magnetic Resonance and Molecular Dynamics Studies , 2014, Biochemistry.

[18]  J. Skehel,et al.  Structures of receptor complexes formed by hemagglutinins from the Asian Influenza pandemic of 1957 , 2009, Proceedings of the National Academy of Sciences.

[19]  Laura Belvisi,et al.  Determination of the binding epitope of RGD-peptidomimetics to αvβ3 and α(IIb)β3 integrin-rich intact cells by NMR and computational studies. , 2013, Organic & biomolecular chemistry.

[20]  Martin H. Koldijk,et al.  New Class of Monoclonal Antibodies against Severe Influenza: Prophylactic and Therapeutic Efficacy in Ferrets , 2010, PloS one.

[21]  Shibo Jiang,et al.  Roles of the hemagglutinin of influenza A virus in viral entry and development of antiviral therapeutics and vaccines , 2010, Protein & Cell.

[22]  Y. Kimura,et al.  Protecting-Group-Free Synthesis of Glycopolymers Bearing Sialyloligosaccharide and Their High Binding with the Influenza Virus. , 2014, ACS macro letters.

[23]  Hiroki Inoue,et al.  Sialic acid-mimic peptides as hemagglutinin inhibitors for anti-influenza therapy. , 2010, Journal of medicinal chemistry.

[24]  M. Civera,et al.  STD and trNOESY NMR Study of Receptor–Ligand Interactions in Living Cancer Cells , 2011, ChemBioChem.

[25]  J. Skehel,et al.  Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. , 2000, Annual review of biochemistry.

[26]  K. Ribbeck,et al.  Antiviral Agents from Multivalent Presentation of Sialyl Oligosaccharides on Brush Polymers. , 2016, ACS Macro Letters.

[27]  J. N. Varghese,et al.  Structure of the catalytic and antigenic sites in influenza virus neuraminidase , 1983, Nature.

[28]  Aravind Srinivasan,et al.  Glycans as receptors for influenza pathogenesis , 2010, Glycoconjugate Journal.

[29]  C. Staib,et al.  Marker gene swapping facilitates recombinant Modified Vaccinia Virus Ankara production by host-range selection. , 2009, Journal of virological methods.

[30]  J. N. Varghese,et al.  Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 Å resolution , 1983, Nature.

[31]  I. Wilson,et al.  Structural Characterization of the Hemagglutinin Receptor Specificity from the 2009 H1N1 Influenza Pandemic , 2011, Journal of Virology.

[32]  Carsten Kutzner,et al.  GROMACS 4:  Algorithms for Highly Efficient, Load-Balanced, and Scalable Molecular Simulation. , 2008, Journal of chemical theory and computation.

[33]  Peter J. Simpson,et al.  NMR of proteins and nucleic acids , 2015 .

[34]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[35]  A. Srinivasan,et al.  Glycan topology determines human adaptation of avian H5N1 virus hemagglutinin , 2008, Nature Biotechnology.

[36]  Thomas Peters,et al.  NMR spectroscopy techniques for screening and identifying ligand binding to protein receptors. , 2003, Angewandte Chemie.